Related Experiment Video
Updated: Aug 7, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement
Barry A Borlaug1, Kavita Sharma2, Sanjiv J Shah3
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Insights
Heart failure with preserved ejection fraction (HFpEF) is increasingly common. Early recognition and tailored treatments are vital for improving outcomes in this complex condition.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Background:
- Heart failure with preserved ejection fraction (HFpEF) incidence and prevalence are rising due to aging, obesity, and cardiometabolic disorders.
- Despite advances in understanding HFpEF pathophysiology and diagnosis, it remains under-recognized in clinical practice.
- Effective treatments exist, highlighting the need for improved recognition and individualized care.
Purpose of the Study:
- To provide an updated examination of HFpEF epidemiology, pathophysiology, diagnosis, and treatment.
- To emphasize the importance of phenotyping for personalized HFpEF management.
- To address the under-recognition of HFpEF in clinical practice.
Main Methods:
- Review of current literature on HFpEF.
- Analysis of epidemiological trends and risk factors.
- Examination of pathophysiological mechanisms across cardiac, pulmonary, and extracardiac systems.
- Evaluation of diagnostic strategies and treatment modalities.
Main Results:
- HFpEF is a heterogeneous syndrome with increasing prevalence.
- Under-recognition of HFpEF hinders timely and effective treatment.
- Pathophysiological phenotyping is crucial for individualized treatment strategies.
- Pharmacologic and lifestyle interventions show promise in improving HFpEF outcomes.
Conclusions:
- HFpEF requires greater clinical attention due to its rising prevalence and significant morbidity.
- Accurate diagnosis and phenotyping are essential for optimizing patient care.
- Personalized treatment approaches, including pharmacologic and lifestyle interventions, can improve clinical status and reduce mortality in HFpEF.
Abstract:
The incidence and prevalence of heart failure with preserved ejection fraction (HFpEF) continue to rise in tandem with the increasing age and burdens of obesity, sedentariness, and cardiometabolic disorders. Despite recent advances in the understanding of its pathophysiological effects on the heart, lungs, and extracardiac tissues, and introduction of new, easily implemented approaches to diagnosis, HFpEF remains under-recognized in everyday practice. This under-recognition presents an even greater concern given the recent identification of highly effective pharmacologic-based and lifestyle-based treatments that can improve clinical status and reduce morbidity and mortality. HFpEF is a heterogenous syndrome and recent studies have suggested an important role for careful, pathophysiological-based phenotyping to improve patient characterization and to better individualize treatment. In this JACC Scientific Statement, we provide an in-depth and updated examination of the epidemiology, pathophysiology, diagnosis, and treatment of HFpEF.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management

